IN Japan reported 20 deaths aft the assignment Tavneos. Regulators are checking the hazard of terrible liver damage.
Around the cause Tavneos companies Amgen there was superior interest pursuing reports from Japan: astatine slightest 20 patientswho took the cause died owed to terrible liver dysfunction. However, a nonstop cause-and-effect narration with the cause has not been confirmed successful each cases.
According to ReutersJapanese institution Kissei Pharmaceuticalwhich sells the cause successful Japan, recommended that doctors temporarily not prescribe Tavneos caller patients and reappraisal already started treatment regimens. The crushed is the hazard of superior liver damage.
According to Kisseipart of the fatal cases to April 27 has been associated with terrible liver illness that damages the bile ducts. In the aesculapian lit this information is known arsenic vanishing bile duct syndrome (vanishing bile duct syndrome). This is simply a uncommon but highly unsafe complication that tin pb to terrible liver failure.
What is known astir the drug
Tavneosactive substance avacopan (avacopan), used to treat terrible progressive ANCA-associated vasculitis. This is simply a radical of uncommon autoimmune diseases successful which small and medium-sized humor vessels go inflamed.
The cause was approved successful USA V 2021and successful Japan entered the marketplace successful 2022. Company Amgen received Tavneos aft acquisition ChemoCentryx for $3.7 billion. In Japan, according to Reuters, since the motorboat of the drug, astir 8,503 patients. Most terrible cases of liver damage, arsenic noted by Kisseiarose during the archetypal three months therapy.
The cause is besides available successful Greeceas reported separately by Greek media. However, patients should not stop treatment connected their own: such decisions should lone beryllium made with the attending physician, since the illness for which it is prescribed Tavneosin itself tin beryllium hard and dangerous.
What does the FDA do?
US Food and Drug Administration (FDA) backmost successful March 2026 issued a warning astir superior liver harm successful patients taking Tavneos. According to the regulator, dozens of cases of drug-induced liver damage, including terrible outcomes and deaths, person been identified.
Later FDA projected to withdraw support Tavneos successful the USA. As helium writes Reutersthe regulator cited not lone reports of liver damage, but besides questions astir the grounds of effectiveness and information presented during the drug’s archetypal approval.
Amgenfor its part, states that it remains assured successful the benefit-risk illustration of the cause and emphasizes its value for patients with terrible progressive ANCA-associated vasculitis. The institution besides indicates that it continues to sermon the situation with regulators.
What is important to patients
The main happening present is not to panic and not marque autarkic decisions. For patients who take Tavneosyou should urgently sermon the situation with your doctor, particularly if there are signs of imaginable liver damage: terrible fatigue, yellow skin oregon eyes, acheronian urine, symptom successful the close precocious abdomen, nausea, nonaccomplishment of appetite, oregon unusual itching.
Doctors, according to warnings from regulators and the institution Kisseishould intimately show liver relation tests, particularly successful the archetypal months of therapy, and instantly reconsider treatment if laboratory oregon objective signs of impairment appear. This is however medicine reminds us again: adjacent a uncommon cause for a uncommon illness tin origin a very communal occupation if power is weak.
Editorial comment
History with Tavneos shows however important post-registration power of drugs is, particularly drugs for uncommon and superior diseases. Clinical trials bash not ever place each risks, and real-world information aft a cause is marketed whitethorn alteration the information assessment.
But present we request to beryllium cautious with the wording. It cannot beryllium automatically assumed that the cause caused each deaths successful Japan: the transportation has not been confirmed successful each cases. However, when it comes to dozens of terrible liver injuries, deaths and a imaginable callback process FDAregulators, doctors and patients should take the awesome arsenic earnestly arsenic possible. No panic, but besides nary soothing pharmaceutical fog.
Greek (GR) · 
English (US) ·